Sustained NMDA receptor hypofunction induces compromised neural systems integration and schizophrenia-like alterations in functional brain networks.

Compromised functional integration between cerebral subsystems and dysfunctional brain network organization may underlie the neurocognitive deficits seen in psychiatric disorders. Applying topological measures from network science to brain imaging data allows the quantification of complex brain network connectivity. While this approach has recently been used to further elucidate the nature of brain dysfunction in schizophrenia, the value of applying this approach in preclinical models of psychiatric disease has not been recognized. For the first time, we apply both established and recently derived algorithms from network science (graph theory) to functional brain imaging data from rats treated subchronically with the N-methyl-D-aspartic acid (NMDA) receptor antagonist phencyclidine (PCP). We show that subchronic PCP treatment induces alterations in the global properties of functional brain networks akin to those reported in schizophrenia. Furthermore, we show that subchronic PCP treatment induces compromised functional integration between distributed neural systems, including between the prefrontal cortex and hippocampus, that have established roles in cognition through, in part, the promotion of thalamic dysconnectivity. We also show that subchronic PCP treatment promotes the functional disintegration of discrete cerebral subsystems and also alters the connectivity of neurotransmitter systems strongly implicated in schizophrenia. Therefore, we propose that sustained NMDA receptor hypofunction contributes to the pathophysiology of dysfunctional brain network organization in schizophrenia.

[1]  B. Morris,et al.  Advancing schizophrenia drug discovery: optimizing rodent models to bridge the translational gap , 2012, Nature Reviews Drug Discovery.

[2]  Neil Dawson,et al.  Modafinil reverses phencyclidine-induced deficits in cognitive flexibility, cerebral metabolism, and functional brain connectivity. , 2012, Schizophrenia bulletin.

[3]  K. Lesch,et al.  Cerebral metabolic responses to 5-HT2A/C receptor activation in mice with genetically modified serotonin transporter (SERT) expression , 2011, European Neuropsychopharmacology.

[4]  Desmond J. Higham,et al.  Exploring metabolic pathway disruption in the subchronic phencyclidine model of schizophrenia with the Generalized Singular Value Decomposition , 2011, BMC Systems Biology.

[5]  Ee Peng Lim,et al.  Locus coeruleus stimulation and noradrenergic modulation of hippocampo-prefrontal cortex long-term potentiation. , 2010, The international journal of neuropsychopharmacology.

[6]  N. Plath,et al.  Translational Aspects of the Novel Object Recognition Task in Rats Abstinent Following Sub-Chronic Treatment with Phencyclidine (PCP): Effects of Modafinil and Relevance to Cognitive Deficits in Schizophrenia , 2010, Front. Psychiatry.

[7]  E. Bullmore,et al.  Behavioral / Systems / Cognitive Functional Connectivity and Brain Networks in Schizophrenia , 2010 .

[8]  S. Taylor,et al.  Low-frequency BOLD fluctuations demonstrate altered thalamocortical connectivity in schizophrenia. , 2010, Schizophrenia bulletin.

[9]  Eleanor H. Simpson,et al.  A Possible Role for the Striatum in the Pathogenesis of the Cognitive Symptoms of Schizophrenia , 2010, Neuron.

[10]  A. Mechelli,et al.  Functional integration between the posterior hippocampus and prefrontal cortex is impaired in both first episode schizophrenia and the at risk mental state. , 2009, Brain : a journal of neurology.

[11]  Philip D. Harvey Pharmacological Cognitive Enhancement in Schizophrenia , 2009, Neuropsychology Review.

[12]  O. Sporns,et al.  Complex brain networks: graph theoretical analysis of structural and functional systems , 2009, Nature Reviews Neuroscience.

[13]  E. Bullmore,et al.  Hierarchical Organization of Human Cortical Networks in Health and Schizophrenia , 2008, The Journal of Neuroscience.

[14]  Yasuo Terayama,et al.  Use of Neuromelanin-Sensitive MRI to Distinguish Schizophrenic and Depressive Patients and Healthy Individuals Based on Signal Alterations in the Substantia Nigra and Locus Ceruleus , 2008, Biological Psychiatry.

[15]  Jeremy D. Schmahmann,et al.  Disconnection syndromes of basal ganglia, thalamus, and cerebrocerebellar systems , 2008, Cortex.

[16]  M. Minzenberg,et al.  Modafinil: A Review of Neurochemical Actions and Effects on Cognition , 2008, Neuropsychopharmacology.

[17]  B. Morris,et al.  Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats , 2008, Psychopharmacology.

[18]  H. Eichenbaum,et al.  Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting , 2008, Neuroscience.

[19]  Yong He,et al.  Disrupted small-world networks in schizophrenia. , 2008, Brain : a journal of neurology.

[20]  A. Egerton,et al.  Modelling prefrontal cortex deficits in schizophrenia: implications for treatment , 2008, British journal of pharmacology.

[21]  T. Robbins,et al.  Lesions of the dorsal noradrenergic bundle impair attentional set‐shifting in the rat , 2007, The European journal of neuroscience.

[22]  R. Vertes,et al.  Nucleus reuniens of the midline thalamus: Link between the medial prefrontal cortex and the hippocampus , 2007, Brain Research Bulletin.

[23]  T. Spencer,et al.  Modafinil Occupies Dopamine and Norepinephrine Transporters in Vivo and Modulates the Transporters and Trace Amine Activity in Vitro , 2006, Journal of Pharmacology and Experimental Therapeutics.

[24]  C. Stam,et al.  Small-world networks and disturbed functional connectivity in schizophrenia , 2006, Schizophrenia Research.

[25]  H. Barbas,et al.  Prefrontal Projections to the Thalamic Reticular Nucleus form a Unique Circuit for Attentional Mechanisms , 2006, The Journal of Neuroscience.

[26]  E. Bullmore,et al.  Functional dysconnectivity in schizophrenia associated with attentional modulation of motor function. , 2005, Brain : a journal of neurology.

[27]  A. Meyer-Lindenberg,et al.  Regionally specific disturbance of dorsolateral prefrontal-hippocampal functional connectivity in schizophrenia. , 2005, Archives of general psychiatry.

[28]  Hae-Jeong Park,et al.  Functional disconnection of the semantic networks in schizophrenia , 2005, Neuroreport.

[29]  G. Dawson,et al.  Assessment of modafinil on attentional processes in a five-choice serial reaction time test in the rat , 2005, Journal of psychopharmacology.

[30]  Brian J. Morris,et al.  Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia , 2005, Psychopharmacology.

[31]  Brian J. Morris,et al.  The atypical antipsychotic drug clozapine enhances chronic PCP-induced regulation of prefrontal cortex 5-HT2A receptors , 2004, Neuropharmacology.

[32]  Kenichi Yamamoto,et al.  Proposal for a noradrenaline hypothesis of schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[33]  Luke Clark,et al.  Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia , 2004, Neuropsychopharmacology.

[34]  R. Vertes Differential projections of the infralimbic and prelimbic cortex in the rat , 2004, Synapse.

[35]  J. Glowinski,et al.  Anatomical and electrophysiological evidence for a direct projection from ammon's horn to the medial prefrontal cortex in the rat , 2004, Experimental Brain Research.

[36]  A. Arnsten Adrenergic targets for the treatment of cognitive deficits in schizophrenia , 2004, Psychopharmacology.

[37]  J. Hollerman,et al.  Changes in behavior-related neuronal activity in the striatum during learning , 2003, Trends in Neurosciences.

[38]  Hae-Jeong Park,et al.  Functional disconnection between the prefrontal and parietal cortices during working memory processing in schizophrenia: a[15(O)]H2O PET study. , 2003, The American journal of psychiatry.

[39]  S. File,et al.  Modafinil affects mood, but not cognitive function, in healthy young volunteers , 2003, Human psychopharmacology.

[40]  B. Morris,et al.  Induction of Metabolic Hypofunction and Neurochemical Deficits after Chronic Intermittent Exposure to Phencyclidine: Differential Modulation by Antipsychotic Drugs , 2003, Neuropsychopharmacology.

[41]  J. Crabtree,et al.  New Intrathalamic Pathways Allowing Modality-Related and Cross-Modality Switching in the Dorsal Thalamus , 2002, The Journal of Neuroscience.

[42]  B. Morris,et al.  Induction of differential patterns of local cerebral glucose metabolism and immediate-early genes by acute clozapine and haloperidol , 2002, Neuropharmacology.

[43]  R. Guillery,et al.  Thalamic Relay Functions and Their Role in Corticocortical Communication Generalizations from the Visual System , 2002, Neuron.

[44]  R. Vertes,et al.  Analysis of projections from the medial prefrontal cortex to the thalamus in the rat, with emphasis on nucleus reuniens , 2002, The Journal of comparative neurology.

[45]  S. Nicolaidis,et al.  Variations in extracellular monoamines in the prefrontal cortex and medial hypothalamus after modafinil administration: a microdialysis study in rats , 2001, Neuroreport.

[46]  A. Young,et al.  Corticosterone selectively attenuates 8-OH-DPAT-mediated hypothermia in mice. , 2001, The international journal of neuropsychopharmacology.

[47]  A. Geva,et al.  Functional Connectivity and Working Memory in Schizophrenia: An Eeg Study , 2001, The International journal of neuroscience.

[48]  K. Fuxe,et al.  Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil , 2000, Neuropharmacology.

[49]  M. Emre,et al.  Evidence‐based pharmacological treatment of dementia , 2000, European journal of neurology.

[50]  Nikolaus R. McFarland,et al.  Striatonigrostriatal Pathways in Primates Form an Ascending Spiral from the Shell to the Dorsolateral Striatum , 2000, The Journal of Neuroscience.

[51]  S Laroche,et al.  Plasticity at hippocampal to prefrontal cortex synapses: Dual roles in working memory and consolidation , 2000, Hippocampus.

[52]  B. Bogerts,et al.  Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons , 1998, Psychiatry Research: Neuroimaging.

[53]  R. Murray,et al.  The dysplastic net hypothesis: an integration of developmental and dysconnectivity theories of schizophrenia , 1997, Schizophrenia Research.

[54]  N C Andreasen,et al.  Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[55]  T. Jay,et al.  NMDA Receptor‐dependent Long‐term Potentiation in the Hippocampal Afferent Fibre System to the Prefrontal Cortex in the Rat , 1995, The European journal of neuroscience.

[56]  Karl J. Friston,et al.  Schizophrenia: a disconnection syndrome? , 1995, Clinical neuroscience.

[57]  C. Guilleminault,et al.  Modafinil binds to the dopamine uptake carrier site with low affinity. , 1994, Sleep.

[58]  D. Weinberger,et al.  Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. , 1992, The American journal of psychiatry.

[59]  S. Potkin,et al.  Positron emission tomography study of phencyclidine users , 1991, Schizophrenia Research.

[60]  T. Newell,et al.  Recovery of neuropsychological functions during reduction in use of phencyclidine. , 1991, Journal of clinical psychology.

[61]  E. Kotlyarov,et al.  Single photon emission computed tomography in phencyclidine and related drug abuse. , 1990, The American journal of psychiatry.

[62]  J. Olney,et al.  Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. , 1989, Science.

[63]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[64]  M. Reivich,et al.  THE [14C]DEOXYGLUCOSE METHOD FOR THE MEASUREMENT OF LOCAL CEREBRAL GLUCOSE UTILIZATION: THEORY, PROCEDURE, AND NORMAL VALUES IN THE CONSCIOUS AND ANESTHETIZED ALBINO RAT 1 , 1977, Journal of neurochemistry.

[65]  K. Fuxe,et al.  DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS. , 1964, Life sciences.